Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of 5-dose versus 4-dose freeze-dried human rabies vaccine (MRC-5 cells)
ChiCTR1900025529Phase 3Not yet recruiting
- Sponsor
- Hunan Center for Disease Control and Prevention
- Start
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Rabies vaccine (MRC-5 cells) and rabies virus inactivated antigen, B in rabies (5 arms), sponsored by Hunan Center for Disease Control and Prevention. Primary endpoints: Positive conversion of antibody, Geometric mean concentration and 4 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
Rabies vaccine (MRC-5 cells)rabies virus inactivated antigen, B
03
Conditions
rabies
Beyond the preview
Go deeper on ChiCTR1900025529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025529.